DCA12_TNX-103-08 OLE - Clinical Trial
Who Can Participate in the Study?
Age Group
Adults
Study Details
Full Title
DCA12: A Multicenter, Open-label, Long-term Extension Study for Oral Levosimendan (TNX-103-08)
Principal Investigator
Marat Fudim, MD, MHS
Advanced Heart Failure Specialist
Protocol Number
IRB:
PRO00120435
NCT:
NCT07436689
Phase
Phase III
ClinicalTrials.gov
View on ClinicalTrials.gov
Enrollment Status
Open for Enrollment